alejandro tommasi glutathione Immunocal alejandro tommasi glutathione Protective Effect

The future of peptide therapy looks brighter every day

NEJM 2025 (REDEFINE-2) Novo Nordisk FDA NDA submission announcement (December 18, 2025) Eli Lilly TRIUMPH-4 topline results (December 2025) Frequently Asked Questions Retatrutide produces higher weight loss at 28.7% versus CagriSema's 20.4%a difference of 21 pounds for a 250-pound person

The medicine is designed to be administered less frequently than Wegovy and Zepbound with injections once a month or less, compared with current drugs weekly shots

Shen et al., 2021)

Lifestyle factors and reproductive health: taking control of your fertility

Microglia and astrocytes in disease: Dynamic duo or partners in crime